| Author: Jo Ann Jenkins, CEO, AARP

Longevity and the Future of Health

Milken Institute
Featured

Related Content

Related Content

Insight
Sample Featured Image Alt

The Value of Collaboration in Rare Disease Research

Childhood brain cancers are among the rarest and most difficult to treat, but new models of collaboration are changing what’s possible. This article explores how philanthropy, advocacy, and cross-sector partnerships are breaking down barriers and accelerating progress toward better treatments.